Maki DG - Search Results

1

Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.

Eastman ME, Khorsand M, Maki DG, Williams EC, Kim K, Sondel PM, Schiller JH, Albertini MR. Eastman ME, et al. Among authors: maki dg. Cancer. 2001 Feb 15;91(4):806-14. Cancer. 2001. PMID: 11241250

2

Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients.

Safdar N, Maki DG. Safdar N, et al. Among authors: maki dg. Chest. 2005 Aug;128(2):489-95. doi: 10.1378/chest.128.2.489. Chest. 2005. PMID: 16100130 Review.

3

Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters.

Safdar N, Maki DG. Safdar N, et al. Among authors: maki dg. Crit Care Med. 2002 Dec;30(12):2632-5. doi: 10.1097/00003246-200212000-00003. Crit Care Med. 2002. PMID: 12483050

4

Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection.

Safdar N, Fine JP, Maki DG. Safdar N, et al. Among authors: maki dg. Ann Intern Med. 2005 Mar 15;142(6):451-66. doi: 10.7326/0003-4819-142-6-200503150-00011. Ann Intern Med. 2005. PMID: 15767623

5

Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials.

Safdar N, Maki DG. Safdar N, et al. Among authors: maki dg. Clin Infect Dis. 2006 Aug 15;43(4):474-84. doi: 10.1086/505976. Epub 2006 Jul 11. Clin Infect Dis. 2006. PMID: 16838237 Review.

6

Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

Maki DG, Stolz SM, Wheeler S, Mermel LA. Maki DG, et al. Ann Intern Med. 1997 Aug 15;127(4):257-66. doi: 10.7326/0003-4819-127-4-199708150-00001. Ann Intern Med. 1997. PMID: 9265424 Clinical Trial.

7

The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices.

Crnich CJ, Maki DG. Crnich CJ, et al. Among authors: maki dg. Clin Infect Dis. 2002 May 15;34(10):1362-8. doi: 10.1086/340105. Epub 2002 Apr 17. Clin Infect Dis. 2002. PMID: 11981732

8

The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters.

Safdar N, Maki DG. Safdar N, et al. Among authors: maki dg. Intensive Care Med. 2004 Jan;30(1):62-7. doi: 10.1007/s00134-003-2045-z. Epub 2003 Nov 26. Intensive Care Med. 2004. PMID: 14647886

9

Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries.

Maki DG, Rosenthal VD, Salomao R, Franzetti F, Rangel-Frausto MS. Maki DG, et al. Infect Control Hosp Epidemiol. 2011 Jan;32(1):50-8. doi: 10.1086/657632. Epub 2010 Dec 1. Infect Control Hosp Epidemiol. 2011. PMID: 21121815

10

Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial.

Maki DG, Ringer M. Maki DG, et al. Ann Intern Med. 1991 May 15;114(10):845-54. doi: 10.7326/0003-4819-114-10-845. Ann Intern Med. 1991. PMID: 2014945 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters